Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.

Nguyen THM, Carreira PE, Sanchez-Luque FJ, Schauer SN, Fagg AC, Richardson SR, Davies CM, Jesuadian JS, Kempen MHC, Troskie RL, James C, Beaven EA, Wallis TP, Coward JIG, Chetty NP, Crandon AJ, Venter DJ, Armes JE, Perrin LC, Hooper JD, Ewing AD, Upton KR, Faulkner GJ.

Cell Rep. 2018 Jun 26;23(13):3730-3740. doi: 10.1016/j.celrep.2018.05.090.

2.

A point mutation in the pre-ZRS disrupts sonic hedgehog expression in the limb bud and results in triphalangeal thumb-polysyndactyly syndrome.

Potuijt JWP, Baas M, Sukenik-Halevy R, Douben H, Nguyen P, Venter DJ, Gallagher R, Swagemakers SM, Hovius SER, van Nieuwenhoven CA, Galjaard RH, van der Spek PJ, Ahituv N, de Klein A.

Genet Med. 2018 Nov;20(11):1405-1413. doi: 10.1038/gim.2018.18. Epub 2018 Mar 15.

PMID:
29543231
3.

Application of Whole Genome Sequencing Technology in the Investigation of Genetic Causes of Fetal, Perinatal, and Early Infant Death.

Armes JE, Williams M, Price G, Wallis T, Gallagher R, Matsika A, Joy C, Galea M, Gardener G, Leach R, Swagemakers SM, Tearle R, Stubbs A, Harraway J, van der Spek PJ, Venter DJ.

Pediatr Dev Pathol. 2018 Jan-Feb;21(1):54-67. doi: 10.1177/1093526617715528. Epub 2017 Jun 22.

PMID:
28641477
4.

Isolated Ventricular Noncompaction Cardiomyopathy Presenting as Fetal Hydrops at 24 Weeks Gestation.

Armes JE, Squires L, Lourie R, Williams M, Gallagher R, Price G, Stubbs A, Swagemakers SM, van der Spek PJ, Harraway J, Thomas J, Venter DJ.

Pediatr Dev Pathol. 2017 Jun;20(3):245-250. doi: 10.1177/1093526616686235. Epub 2017 Jan 25.

PMID:
28521630
5.

MALDI-TOF MS meets WGS in a VRE outbreak investigation.

Schlebusch S, Price GR, Gallagher RL, Horton-Szar V, Elbourne LD, Griffin P, Venter DJ, Jensen SO, Van Hal SJ.

Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):495-499. doi: 10.1007/s10096-016-2824-4. Epub 2016 Nov 26.

PMID:
27889877
6.

Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis.

Liu C, Gallagher RL, Price GR, Bolton E, Joy C, Harraway J, Venter DJ, Armes JE.

Int J Gynecol Pathol. 2016 Nov;35(6):561-565.

PMID:
27015438
7.

A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts.

McHugh L, Seldon TA, Brandon RA, Kirk JT, Rapisarda A, Sutherland AJ, Presneill JJ, Venter DJ, Lipman J, Thomas MR, Klein Klouwenberg PM, van Vught L, Scicluna B, Bonten M, Cremer OL, Schultz MJ, van der Poll T, Yager TD, Brandon RB.

PLoS Med. 2015 Dec 8;12(12):e1001916. doi: 10.1371/journal.pmed.1001916. eCollection 2015 Dec.

8.

The role of defensive ecological interactions in the evolution of conotoxins.

Prashanth JR, Dutertre S, Jin AH, Lavergne V, Hamilton B, Cardoso FC, Griffin J, Venter DJ, Alewood PF, Lewis RJ.

Mol Ecol. 2016 Jan;25(2):598-615. doi: 10.1111/mec.13504. Epub 2016 Jan 20.

PMID:
26614983
9.

Production and packaging of a biological arsenal: evolution of centipede venoms under morphological constraint.

Undheim EA, Hamilton BR, Kurniawan ND, Bowlay G, Cribb BW, Merritt DJ, Fry BG, King GF, Venter DJ.

Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4026-31. doi: 10.1073/pnas.1424068112. Epub 2015 Mar 16.

10.

The use of thiafentanil oxalate and azaperone for reversible immobilisation of African buffalo (Syncerus caffer) within a nature reserve - Short communication.

Szabó Z, Venter DJ, Luyt Edu C, Raath C.

Acta Vet Hung. 2015 Mar;63(1):11-5. doi: 10.1556/AVet.2015.002.

PMID:
25655411
11.

Evolution of separate predation- and defence-evoked venoms in carnivorous cone snails.

Dutertre S, Jin AH, Vetter I, Hamilton B, Sunagar K, Lavergne V, Dutertre V, Fry BG, Antunes A, Venter DJ, Alewood PF, Lewis RJ.

Nat Commun. 2014 Mar 24;5:3521. doi: 10.1038/ncomms4521.

12.

Multifunctional warheads: diversification of the toxin arsenal of centipedes via novel multidomain transcripts.

Undheim EA, Sunagar K, Hamilton BR, Jones A, Venter DJ, Fry BG, King GF.

J Proteomics. 2014 May 6;102:1-10. doi: 10.1016/j.jprot.2014.02.024. Epub 2014 Mar 3.

PMID:
24602922
13.

Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects.

Zamzami MA, Duley JA, Price GR, Venter DJ, Yarham JW, Taylor RW, Catley LP, Florin TH, Marinaki AM, Bowling F.

J Hematol Oncol. 2013 Mar 29;6:24. doi: 10.1186/1756-8722-6-24.

14.

Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases.

Samaraweera SE, O'Keefe LV, Price GR, Venter DJ, Richards RI.

Hum Mol Genet. 2013 Jul 15;22(14):2811-9. doi: 10.1093/hmg/ddt130. Epub 2013 Mar 21.

15.

High resolution spatial mapping of brominated pyrrole-2-aminoimidazole alkaloids distributions in the marine sponge Stylissa flabellata via MALDI-mass spectrometry imaging.

Yarnold JE, Hamilton BR, Welsh DT, Pool GF, Venter DJ, Carroll AR.

Mol Biosyst. 2012 Sep;8(9):2249-59. Epub 2012 Jul 9.

PMID:
22777271
16.

Implementation of intravenous to oral antibiotic switch therapy guidelines in the general medical wards of a tertiary-level hospital in South Africa.

van Niekerk AC, Venter DJ, Boschmans SA.

J Antimicrob Chemother. 2012 Mar;67(3):756-62. doi: 10.1093/jac/dkr526. Epub 2011 Dec 13.

PMID:
22167244
17.

Perturbation of the Akt/Gsk3-β signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs.

van Eyk CL, O'Keefe LV, Lawlor KT, Samaraweera SE, McLeod CJ, Price GR, Venter DJ, Richards RI.

Hum Mol Genet. 2011 Jul 15;20(14):2783-94. doi: 10.1093/hmg/ddr177. Epub 2011 Apr 25.

18.

Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach.

Armes JE, Bowlay G, Lourie R, Venter DJ, Price G.

Pathology. 2010;42(6):534-9. doi: 10.3109/00313025.2010.508793.

PMID:
20854071
19.

Laparoscopic-assisted pull-through for congenital rectal stenosis.

van Niekerk ML, Visser A, Venter DJ.

J Laparoendosc Adv Surg Tech A. 2010 Feb;20(1):107-9. doi: 10.1089/lap.2008.0343.

PMID:
19432530
20.

Phenotype-directed analysis of genotype in early-onset, familial breast cancers.

Price GR, Armes JE, Ramus SJ, Provenzano E, Kumar B, Cowie TF, Ciciulla J, Hutchins AM, Thomas M, Venter DJ.

Pathology. 2006 Dec;38(6):520-7.

PMID:
17393978
21.

Laparoscopic antireflux surgery in infants and children.

Van Niekerk ML, Visser A, Venter DJ.

S Afr Med J. 2005 Sep;95(9):675-7. No abstract available.

22.

Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein.

Armes JE, Lourie R, de Silva M, Stamaratis G, Boyd A, Kumar B, Price G, Hyde S, Allen D, Grant P, Venter DJ.

Int J Gynecol Pathol. 2005 Oct;24(4):363-8.

PMID:
16175083
23.

Sialin, an anion transporter defective in sialic acid storage diseases, shows highly variable expression in adult mouse brain, and is developmentally regulated.

Yarovaya N, Schot R, Fodero L, McMahon M, Mahoney A, Williams R, Verbeek E, de Bondt A, Hampson M, van der Spek P, Stubbs A, Masters CL, Verheijen FW, Mancini GM, Venter DJ.

Neurobiol Dis. 2005 Aug;19(3):351-65.

PMID:
16023578
24.

Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines.

Venter DJ, Ramus SJ, Hammet FM, de Silva M, Hutchins AM, Petrovic V, Price G, Armes JE.

Cancer Genet Cytogenet. 2005 Jul 15;160(2):134-40.

PMID:
15993269
25.

Food choice of tactile defensive children.

Smith AM, Roux S, Naidoo NT, Venter DJ.

Nutrition. 2005 Jan;21(1):14-9.

PMID:
15729777
26.

Histology of the fascial-periosteal interface in lower limb chronic deep posterior compartment syndrome.

Barbour TD, Briggs CA, Bell SN, Bradshaw CJ, Venter DJ, Brukner PD.

Br J Sports Med. 2004 Dec;38(6):709-17.

27.

Tissue microarrays: a practical guide.

Kumar B, De Silva M, Venter DJ, Armes JE.

Pathology. 2004 Aug;36(4):295-300. Review.

PMID:
15370126
28.

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.

John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D; Breast Cancer Family Registry.

Breast Cancer Res. 2004;6(4):R375-89. Epub 2004 May 19.

29.

Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.

Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE.

Pathology. 2004 Jun;36(3):221-9.

PMID:
15203725
30.

Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers.

Armes JE, Hammet F, de Silva M, Ciciulla J, Ramus SJ, Soo WK, Mahoney A, Yarovaya N, Henderson MA, Gish K, Hutchins AM, Price GR, Venter DJ.

Oncogene. 2004 Jul 22;23(33):5697-702.

PMID:
15184884
31.

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status.

McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL.

Br J Cancer. 2003 Nov 3;89(9):1661-3.

32.

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA).

Apicella C, Andrews L, Hodgson SV, Fisher SA, Lewis CM, Solomon E, Tucker K, Friedlander M, Bankier A, Southey MC, Venter DJ, Hopper JL.

Breast Cancer Res. 2003;5(6):R206-16. Epub 2003 Aug 28.

33.

A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1.

Southey MC, Tesoriero A, Young MA, Holloway AJ, Jenkins MA, Whitty J, Misfud S, kConFab, McLachlan SA, Venter DJ, Armes JE.

Hum Mutat. 2003 Jul;22(1):86-91.

PMID:
12815598
34.

Searching for candidate genes for male infertility.

Truong BN, Moses EK, Armes JE, Venter DJ, Baker HW.

Asian J Androl. 2003 Jun;5(2):137-47. Erratum in: Asian J Androl. 2003 Sep;5(3):230.

35.

Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.

Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL.

Genet Epidemiol. 2003 Apr;24(3):161-72.

PMID:
12652520
36.

Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL.

J Natl Cancer Inst. 2003 Mar 19;95(6):448-57.

PMID:
12644538
37.

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.

Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE.

Eur J Cancer. 2003 Mar;39(5):622-30.

PMID:
12628841
38.

Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.

Willis S, Hutchins AM, Hammet F, Ciciulla J, Soo WK, White D, van der Spek P, Henderson MA, Gish K, Venter DJ, Armes JE.

Genes Chromosomes Cancer. 2003 Apr;36(4):382-92.

PMID:
12619162
39.

After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families.

Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, Mead LJ, St John DJ, Macrae FA, Bishop DT, Venter DJ, Giles GG, Hopper JL.

Int J Cancer. 2002 Nov 10;102(2):166-71.

40.

The pathology of inherited breast cancer.

Armes JE, Venter DJ.

Pathology. 2002 Aug;34(4):309-14. Review.

PMID:
12190286
41.

Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.

Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Godwin AK, Hopper JL, Li F, Neuhausen SL, Ozcelik H, Peel D, Santella RM, Southey MC, van Orsouw NJ, Venter DJ, Vijg J, Whittemore AS; Cooperative Family Registry for Breast Cancer studies.

Hum Mutat. 2002 Jul;20(1):65-73.

PMID:
12112659
42.

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.

Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G.

Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):439-43.

43.

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.

Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G.

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):413-6.

44.

Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer.

Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ.

Cancer Res. 2002 Mar 1;62(5):1289-95.

45.

Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma.

Schmitt JF, Millar DS, Pedersen JS, Clark SL, Venter DJ, Frydenberg M, Molloy PL, Risbridger GP.

Mol Endocrinol. 2002 Feb;16(2):213-20.

PMID:
11818495
46.

The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.

Spurdle AB, Hopper JL, Chen X, Dite GS, McCredie MR, Giles GG, Venter DJ, Southey MC, Purdie DM, Chenevix-Trench G.

Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1287-93.

47.

Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs.

Lahoud MH, Ristevski S, Venter DJ, Jermiin LS, Bertoncello I, Zavarsek S, Hasthorpe S, Drago J, de Kretser D, Hertzog PJ, Kola I.

Genome Res. 2001 Aug;11(8):1327-34.

48.

Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis.

Southey MC, Young MA, Whitty J, Mifsud S, Keilar M, Mead L, Trute L, Aittomäki K, McLachlan SA, Debinski H, Venter DJ, Armes JE.

Am J Surg Pathol. 2001 Jul;25(7):936-41.

PMID:
11420466
50.

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MR, Hopper JL.

Am J Hum Genet. 2001 Feb;68(2):420-31. Epub 2000 Dec 27.

Supplemental Content

Loading ...
Support Center